Your session is about to expire
← Back to Search
Labs for Neuroblastoma (NEPENTHE Trial)
NEPENTHE Trial Summary
This trial is testing personalized cancer treatment based on a patient's individual tumor genomic changes.
- Neuroblastoma
- Cancer
NEPENTHE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowNEPENTHE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.NEPENTHE Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is this endeavor an unprecedented effort?
"Labs has been the subject of clinical trials since 2012, when it was first endorsed by pharmaceutical giant Pfizer. Following its initial study involving 189 individuals, Labs received approval for Phase 1 and 2 drug testing. Currently, 58 ongoing studies are taking place throughout 786 cities in 49 countries worldwide."
What is the upper limit of people included in this clinical endeavor?
"Affirmative. Clinicaltrials.gov data reveals that the trial, which was initially announced on July 1st 2016, is currently enrolling participants. This clinical study seeks 131 patients from 2 medical centres."
Is the age range for this study inclusive of individuals over 35 years old?
"According to the stated requirements, individuals between the ages of one year old and twenty-one years old are eligible for enrollment in this clinical trial."
What are the primary purposes of utilizing Labs?
"Labs is the most popular treatment for breast cancer, but it can also be used to manage a variety of other medical issues including malignant neoplasms, non-small cell lung carcinoma, and postmenopause."
Is there still an availability for willing participants in this research project?
"Correct. According to clinicaltrials.gov, the trial is actively recruiting participants; initial posting was on July 1st 2016 and latest update occurred on August 2nd 2022. 131 patients are required from two medical centres for this research study."
How do I sign up to participate in this research?
"This medical trial is enrolling 131 paediatric patients from 1 year to 21 years old who are fighting malignancies. To be eligible, participants need adequate bone marrow function, a sufficient interval between their last dose of anti-cancer therapy and enrollment in the study for recovery purposes, as well as relapsed or refractory neuroblastoma; please contact individual sites for detailed criteria."
Are Lab services hazard-free for individuals?
"Due to a limited amount of data regarding both efficacy and safety, the evaluation team at Power assigned Labs a score of 1 on their scale from 1-3."
Could you provide details on past experiments related to Labs?
"First studied in 2012 at Azienda Ospedaliera Universitaria Federico II, 141 studies have been completed regarding Labs. Currently, 58 clinical trials are ongoing and many of these investigations are located in Philadelphia, Pennsylvania."
Share this study with friends
Copy Link
Messenger